TNF and colitis: Thus, our study has determined that in the DSS-induced mouse model of colitis, DJ-X-013 treatment improves inflammation by inducing MDSCs, which suppress the inflammatory response of immune cells including neutrophils, TNF-α producing macrophages, monocytes, and activated T cells, and inhibit migration of Th17 cells in the colon LP and systemic organs.